Circulating Histone Profiling in Acute Myeloid Leukaemia: Longitudinal Dynamics and Cross-Sectional Comparison with Myelodysplastic Neoplasms with Increased Blasts
4 affiliations
- 1Department of Hematology, Faculty of Medicine, Medical University of Varna, 9002 Varma, Bulgaria
- 2Clinic of Clinical Hematology, St. Marina University Hospital, 9010 Varna, Bulgaria
- 3Department of Stem Cell Biology and Transplantology, Research Institute, Medical University of Varna, 9000 Varna, Bulgaria
- 4Department of Adaptive Biotechnologies, Global Change Research Institute CAS–Czech Academy of Sciences, Bělidla 986/4a, 603 00 Brno, Czech Republic
Abstract
Circulating histones are increasingly recognised as biologically relevant components of extracellular chromatin, but their composition and treatment-associated dynamics in acute myeloid leukaemia (AML) remain poorly defined. In this prospective single-centre observational study, we profiled 13 histone measures by ImageStream imaging flow cytometry in 31 plasma samples from 15 newly diagnosed AML patients at diagnosis/day 7/day 28 (n = 15/10/6), with 30 healthy controls and 12 patients with myelodysplastic neoplasms with increased blasts. At diagnosis, nine of 13 measures differed from controls after false discovery rate (FDR) correction, defining a bidirectional profile with higher H2A-, H2B- and macroH2A1-associated measures and lower H3, H4 and H3/H4; the largest differences included increased macroH2A1.1 (7.07% vs. 0.47%; δ = 0.98) and reduced H4 (0.14% vs. 3.25%; δ = −0.87). By day 7, five measures remained FDR-significant, all decreasing: H4, H3/H4 and the three four-marker-positive populations. At day 28, no paired comparison remained FDR-significant; however, H3/H4 showed a significant overall temporal change across the six complete serial trajectories (q = 0.0334). Exploratory day-28 trajectories showed concordant decreases in all three four-marker-positive populations in patients achieving complete remission, with opposite changes in residual disease; however, the response-stratified comparisons were not statistically significant. MDS with increased blasts showed higher macroH2A1-containing four-marker-positive populations than controls and AML. These findings support disease- and treatment-associated redistribution of circulating histone populations across myeloid neoplasia.
Related
- Artificial Intelligence-Driven Nanosensing to Identify Circulating Bacterial DNA: A Novel Approach to Breast Cancer Risk Profiling
- Multiparametric Extracellular Vesicle Profiling Identifies a Distinct Circulating Signature of Bicuspid Aortic Valve Disease
- Longitudinal metagenomic profiling of gut microbiome dynamics in B-cell lymphoma patients receiving CAR-T cell therapy.
- A spectrum of tumorigenesis in an IDH1-mosaic patient with Ollier disease, acute myeloid leukaemia, and parathyroid adenoma
- tRNA regulatory ecosystem states shape tissue and circulating small-RNA landscapes in gastric cancer
BibTeX
@article{daskalova2026circulating,
title = {{Circulating Histone Profiling in Acute Myeloid Leukaemia: Longitudinal Dynamics and Cross-Sectional Comparison with Myelodysplastic Neoplasms with Increased Blasts}},
author = {Nikol Daskalova and Ilina Micheva and Manlio Vinciguerra and Desislava K. Tsoneva and Diana Buzova and Jan Cerveny and Igor Resnick},
journal = {International Journal of Molecular Sciences},
year = {2026},
month = nov,
doi = {10.3390/ijms272210133},
url = {https://www.mdpi.com/1422-0067/27/22/10133},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Circulating Histone Profiling in Acute Myeloid Leukaemia: Longitudinal Dynamics and Cross-Sectional Comparison with Myelodysplastic Neoplasms with Increased Blasts
AU - Nikol Daskalova
AU - Ilina Micheva
AU - Manlio Vinciguerra
AU - Desislava K. Tsoneva
AU - Diana Buzova
AU - Jan Cerveny
AU - Igor Resnick
PY - 2026
DA - 2026/11/12
JO - International Journal of Molecular Sciences
DO - 10.3390/ijms272210133
UR - https://www.mdpi.com/1422-0067/27/22/10133
AB - Circulating histones are increasingly recognised as biologically relevant components of extracellular chromatin, but their composition and treatment-associated dynamics in acute myeloid leukaemia (AML) remain poorly defined. In this prospective single-centre observational study, we profiled 13 histone measures by ImageStream imaging flow cytometry in 31 plasma samples from 15 newly diagnosed AML patients at diagnosis/day 7/day 28 (n = 15/10/6), with 30 healthy controls and 12 patients with myelodysplastic neoplasms with increased blasts. At diagnosis, nine of 13 measures differed from controls after false discovery rate (FDR) correction, defining a bidirectional profile with higher H2A-, H2B- and macroH2A1-associated measures and lower H3, H4 and H3/H4; the largest differences included increased macroH2A1.1 (7.07% vs. 0.47%; δ = 0.98) and reduced H4 (0.14% vs. 3.25%; δ = −0.87). By day 7, five measures remained FDR-significant, all decreasing: H4, H3/H4 and the three four-marker-positive populations. At day 28, no paired comparison remained FDR-significant; however, H3/H4 showed a significant overall temporal change across the six complete serial trajectories (q = 0.0334). Exploratory day-28 trajectories showed concordant decreases in all three four-marker-positive populations in patients achieving complete remission, with opposite changes in residual disease; however, the response-stratified comparisons were not statistically significant. MDS with increased blasts showed higher macroH2A1-containing four-marker-positive populations than controls and AML. These findings support disease- and treatment-associated redistribution of circulating histone populations across myeloid neoplasia.
SN - 1422-0067
ER -